tradingkey.logo

Autonomix Medical Inc

AMIX

1.340USD

-0.050-3.60%
Close 08/04, 16:00ETQuotes delayed by 15 min
3.35MMarket Cap
LossP/E TTM

Autonomix Medical Inc

1.340

-0.050-3.60%
More Details of Autonomix Medical Inc Company
Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. It is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
Company Info
Ticker SymbolAMIX
Company nameAutonomix Medical Inc
IPO dateJan 29, 2024
CEOMr. Bradley (Brad) Hauser
Number of employees8
Security typeOrdinary Share
Fiscal year-endJan 29
Address- -
City- -
Stock exchangeNASDAQ Capital Market Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolAMIX
IPO dateJan 29, 2024
CEOMr. Bradley (Brad) Hauser
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
103.51K
+2.17%
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
39.05K
+9.20%
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
26.58K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
11.91K
+31.46%
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
103.51K
+2.17%
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
39.05K
+9.20%
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
26.58K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
11.91K
+31.46%
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, Jul 31
Updated: Thu, Jul 31
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Mercer Street Capital Partners, LLC
3.17%
Klemp (Walter V.)
3.03%
Heights Capital Management, Inc.
2.30%
Toth (Landy)
2.05%
Mariner Wealth Advisors
1.99%
Other
87.46%
Shareholders
Shareholders
Proportion
Mercer Street Capital Partners, LLC
3.17%
Klemp (Walter V.)
3.03%
Heights Capital Management, Inc.
2.30%
Toth (Landy)
2.05%
Mariner Wealth Advisors
1.99%
Other
87.46%
Shareholder Types
Shareholders
Proportion
Individual Investor
8.28%
Investment Advisor
7.85%
Hedge Fund
0.67%
Other
83.19%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
39
849.02K
16.81%
+129.90K
2025Q1
38
911.14K
32.77%
+69.62K
2024Q4
37
970.61K
39.41%
+334.04K
2024Q3
33
498.18K
43.25%
+16.51K
2024Q2
26
438.67K
42.98%
+436.93K
2024Q1
16
314.97K
29.85%
+314.97K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Mercer Street Capital Partners, LLC
160.00K
5.75%
+160.00K
--
Nov 25, 2024
Klemp (Walter V.)
150.75K
5.42%
--
--
Oct 25, 2024
Heights Capital Management, Inc.
116.09K
4.18%
-18.91K
-14.01%
Dec 31, 2024
Toth (Landy)
101.31K
3.64%
--
--
Oct 25, 2024
Mariner Wealth Advisors
100.64K
3.62%
+25.00
+0.02%
Mar 31, 2025
Schwartz (Robert)
35.76K
1.29%
+1.00
+0.00%
Oct 25, 2024
Foster (Jonathan P.)
36.56K
1.31%
--
--
Oct 25, 2024
Robins (David Andrew)
26.58K
0.96%
+964.00
+3.76%
Oct 25, 2024
Ikarian Capital LLC
20.00K
0.72%
--
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Oct 22, 2024
Merger
20<1
Oct 22, 2024
Merger
20<1
Oct 22, 2024
Merger
20<1
Oct 22, 2024
Merger
20<1
Date
Type
Ratio
Oct 22, 2024
Merger
20<1
Oct 22, 2024
Merger
20<1
Oct 22, 2024
Merger
20<1
Oct 22, 2024
Merger
20<1
KeyAI